BGC

Pfizer’s sasanlimab and BCG combo therapy improves EFS in bladder cancer trial
Clinical Trials Arena
Mon, 04/28/25 - 09:39 am
Pfizer
clinical trials
sasanlimab
BGC
non-muscle invasive bladder cancer